CFM
COGT icon

Capricorn Fund Managers’s Cogent Biosciences COGT Stock Holding History

Capricorn Fund Managers’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
+41,300
New +$1.45M 0.13% 128

Other funds holding COGT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return

Capricorn Fund Managers's COGT Position: Q2 2026 in Review

Capricorn Fund Managers opened a new position in Cogent Biosciences (COGT) in Q2 2026: 41,300 shares worth $1.6M. The stake represents 0.13% of the portfolio and ranks #128 among its holdings.

32 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Capricorn Fund Managers held 41,300 shares of Cogent Biosciences worth $1.6M as of Q2 2026.
  • Cogent Biosciences was a new Capricorn Fund Managers position in Q2 2026.
  • Cogent Biosciences made up 0.13% of Capricorn Fund Managers's portfolio in Q2 2026, its #128 holding.
  • 32 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.